Amkay Products IPO GMP Today in the Grey Market is Not Available at The Moment. Investors are Advised to Closely Monitor Market Trends and consult Reliable Sources for the Most up-to-date Information. It is Important to Exercise caution and Conduct Thorough Research Before Making Any Investment Decisions.
About Amkay Products IPO-
How Much GMP Price Amkay Products IPO today?, live Grey Market Premium Kostak Rates today live Amkay Products IPO Now . Subject to sauda Rate today, Amkay Products IPO as of today Subject to sauda rates kostak.
Amkay Products IPO is to open on April 30, 2024. Amkay Products is a BSE SME IPO to raise 2,292,000 Shares (Approx ₹12.61 Cr) Via IPO. The Amkay Products IPO Price Band is Fixed At ₹52 to ₹55 Per Every Share With a IPO Lot Size of 2000 Shares.
About Amkay Products Data Like –
- kashyap mody is the CEO of Amkay Products and Amkay Products was founded in the year 2007 and has just completed 17 years in operation.
- We Manufacture, Assemble & Market A Comprehensive Portfolio Of Medical Devices, Disposables And Other Healthcare Products Like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, Surgeon Cap Etc. Used By Healthcare Centers, Hospitals/Clinics, Nursing Homes Etc. Widely Spread Across India. In Addition, We Are Also Engaged In Branding And Marketing Of Some Of The Products Like Diapers, Plastic Gloves, Suction Machines Etc.
- Our Company Started Its Operations In Year 2008 With Manufacturing And Supply Of One Product In A Manufacturing Unit Taken On Rent At Vasai In Mumbai, Measuring 980 Sq. Feet. Gradually, More Products Were Added To Our Portfolio & For Further Product Expansion, Over The Period, We Shifted To Bigger Manufacturing Units From Where We Entered Into Branding & Trading Segment Also Along With Manufacturing.
What is Amkay Products IPO GMP Today?
The Amkay Products IPO GMP Today is ₹25.
What is Amkay Products IPO Sauda Price Today?
The Amkay Products IPO Sauda price Today is ₹38000.
Amkay Products IPO GMP With Per Lot Profit
| DATE | IPO GMP PRICE | EST LISTING PRICE |
|---|---|---|
| 10 May 2024 | ₹62 | ₹117 |
| 9 May 2024 | ₹62 | ₹117 |
| 8 May 2024 | ₹62 | ₹117 |
| 7 May 2024 | ₹59 | ₹114 |
| 6 May 2024 | ₹65 | ₹120 |
| 5 May 2024 | ₹65 | ₹120 |
| 4 May 2024 | ₹65 | ₹120 |
| 3 May 2024 | ₹65 | ₹120 |
| 2 May 2024 | ₹55 | ₹110 |
| 1 May 2024 | ₹46 | ₹101 |
| 30 April 2024 | ₹27 | ₹82 |
| 29 April 2024 | ₹25 | ₹80 |
| 28 April 2024 | ₹25 | ₹80 |
| 27 April 2024 | ₹25 | ₹80 |
| 26 April 2024 | ₹0 | ₹55 |
| 25 April 2024 | ₹0 | ₹55 |
| 24 April 2024 | ₹0 | ₹55 |
Also Read : Amkay Products IPO Details Today, GMP Price, Date, Review
Latest IPO GMP
We Update live GMP status of all upcoming IPOs every day until the IPO gets listed on the stock exchange. You can easily see the GMP price of all IPOs on our IPO GMP dashboard. We update IPO GMP performance regularly on Moneymintidea.com. You can easily get a rough idea of the GMP of all IPOs and what the listing price of the IPO is going to be.
IPO Grey Market Premium (GMP)
Before investing money in any IPO, one should pay more attention to the fact that the IPO GMP price is very volatile, if you are thinking of investing in Amkay Products IPO by looking at the GMP price, then your decision may prove to be quite risky. Before investing in a new IPO, you should have good knowledge about the business of the company. It should be your decision whether to invest in Amkay Products IPO or not and not by looking at the GMP price of the IPO.
Grey Market Premium (GMP) is the price at which an IPO is traded in an informal/unregulated manner before getting listed on the stock exchange. GMP price in the gray market reflects the price at which a company’s IPO is listed. Going to do. A good GMP premium/price gives you an indication of how much profit the IPO will make upon listing. Rather, if the GMP premium of an IPO is negative, then one should avoid investing money in that IPO.
Disclaimer:- The article here should not be construed as an offer to you to buy or sell based on any IPO / Gray Market Premium (GMP) or as advice in any way. The article here is written for informational and educational informational purposes only. This article should not be relied upon for investing in IPOs. Readers should consult a qualified financial advisor before making investment decisions.
Any reader making any investment decision based on the information published here does so entirely at his own risk. Investors should be aware that any investment in the equity market is subject to unpredictable market-related risks. The author does not intend to invest in this offering.
